Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Superseded

This Document Has Been Replaced By: Prevention of pertussis, tetanus, and diphtheria with vaccines in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010

January 14, 2011
By United States. Advisory Committee on Immunization Practices.
Source: MMWR. Morbidity and mortality weekly report. 2011; 60(1):13-5.

[PDF-229.21 KB]

English

Details Related Documents You May Also Like

Details:

Alternative Title:

MMWR. Morbidity and mortality weekly report
Corporate Authors:

United States. Advisory Committee on Immunization Practices.
Description:

Despite sustained high coverage for childhood pertussis vaccination, pertussis remains poorly controlled in the United States. A total of 16,858 pertussis cases and 12 infant deaths were reported in 2009. Although 2005 recommendations by the Advisory Committee on Immunization Practices (ACIP) called for vaccination with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) for adolescents and adults to improve immunity against pertussis, Tdap coverage is 56% among adolescents and <6% among adults. In October 2010, ACIP recommended expanded use of Tdap. This report provides the updated recommendations, summarizes the safety and effectiveness data considered by ACIP, and provides guidance for implementing the recommendations.
Subjects:

[+]

Adolescent Adult Advisory Committees Aged Child Diphtheria-Tetanus-acellular Pertussis Vaccines Humans Immunization, Secondary Immunization Schedule Middle Aged Whooping Cough Young Adult
Source:

MMWR. Morbidity and mortality weekly report. 2011; 60(1):13-5.
Pubmed ID:

21228763
Document Type:

Journal Article
Place as Subject:

United States
Collection(s):

Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR) Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:bbd10d6b54137df8ce5435e556fca51f2dd64525beb7d1a117e933a703fa3e2a
Download URL:

https://stacks.cdc.gov/view/cdc/7455/cdc_7455_DS1.pdf
File Type:

No Additional Files

More +

Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and haemophilus B conjugate vaccine and guidance for use in infants and children

[PDF - 1.60 MB]

:

United States. Advisory Committee on Immunization Practices. ...

October 3, 2008 | MMWR. Morbidity and mortality weekly report. 2008; 57(39):1079-80.

Description:

On June 20, 2008 the Food and Drug Administration (FDA) licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP), in...

Status:

superseded

File Type:

[PDF - 1.60 MB]

File Type:

[PDF - 1.60 MB]
Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine and guidance for use as a booster dose

[PDF - 1.60 MB]

October 3, 2008 | MMWR. Morbidity and mortality weekly report. 2008; 57(39):1078-9.

Description:

On June 24, 2008, the Food and Drug Administration licensed a combined diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP) and inac...

Status:

superseded

File Type:

[PDF - 1.60 MB]

File Type:

[PDF - 1.60 MB]
FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine;

[HTM]

:

Centers for Disease Control and Prevention (U.S.)

April 17, 2009 | MMWR. Morbidity and mortality weekly report. 2009; 58(14):374-5.

Description:

On December 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced diphtheria toxoid and ...

Status:

superseded

File Type:

[HTM]

File Type:

[HTM]
Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants : recommendations of the Advisory Committee on Immunization Practices

[PDF - 492.21 KB]

Personal Author:

Broder, Karen R. ;

Brown, Kristin H.
...

May 30, 2008 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 57, no. RR-4

Description:

"In 2005, two tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines were licensed and recommended for use in adults and a...

Status:

superseded

File Type:

[PDF - 492.21 KB]

File Type:

[PDF - 492.21 KB]

Superseded

Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010

Details:

Supporting Files

Related Documents

You May Also Like